BioClinica - Medical Equipment - Deals and Alliances Profile ---Aarkstore Enterprise Market Research Aggregation

BioClinica - Medical Equipment - Deals and Alliances- Provides key company information for business
Profile is an essential source for company data andintelligence needs
information. The profile examines the company's key- Gives information on the company's major recent
business structure and operations, history andfinancial deals including mergers & acquisitions,
products, and provides summary analysis of its keyasset transactions, PE/VC deals, equity offerings, debt
revenue lines and strategy as well as highlighting theofferings and partnerships.
company's major recent financial deals.- Data is supplemented with details on the company's
BioClinica is a global clinical trials service organization,history, key executives, business description, locations
engaged in providing services to support the productand subsidiaries as well as a list of products and
development process of the pharmaceutical,services and the latest available company statement.
biotechnology, and medical device industries. TheReasons to buy
company principally operates in the U.S. and Europe. It- A quick "one-stop-shop" to understand the company.
is headquartered at Newtown, Pennsylvania, the US.- Support sales activities by understanding your
On May 5, 2009, the company announced to acquirecustomers' businesses.
all of the outstanding shares of etrials Worldwide, Inc., a- Qualify prospective partners and suppliers.
healthcare IT company, for a purchase consideration- Understand and respond to your competitors'
of approximately $9.79 millionbusiness structure, strategy and prospects through.
And More inside the report…- Understanding the key deals which have shaped the
Recent Developmentscompany.
Nov 04, 2009: Bioclinica Reports Total Revenues OfCompany Mentioned
$18.4 Million In Q3 2009The following companies are the major competitors of
Sep 01, 2009: BioClinica Acquires CardioNow FromBioClinica:
Agfa HealthcareENZO BIOCHEM, INC
Aug 06, 2009: Bioclinica Reports Total Revenues OfRadNet, Inc.
$17.1 Million In Q2 2009Pharmaceutical Product Development, Inc.
ScopeSynarc, Inc.